UniProt/SwissProt ID: | TRI29_HUMAN |
Description: | tripartite motif containing 29 [Source:HGNC Symbol;Acc:17274] |
Location: | chr11 q23.3 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S91 | GDDKNsNYFSM | PhosphoSitePlus | |
Y454 | RYVNNyTNSFG | PhosphoSitePlus | |
Y106 | GKRSPyAGLQL | PhosphoSitePlus | |
T139 | ESRKPtVSIME | PhosphoSitePlus | |
S95 | NSNYFsMDSME | PhosphoSitePlus; HPRD | |
S7 | SNGS | HPRD | |
S7 | EAADAsRSNGS | PhosphoSitePlus | |
S141 | RKPTVsIMEPG | PhosphoSitePlus | |
S12 | SRSNGsSPEAR | PhosphoSitePlus; HPRD | |
Y506 | NFNNLyGTKGN | PhosphoSitePlus | |
S488 | TSYQPsSPGRF | PhosphoSitePlus; HPRD | |
S23 | DARSPsGPSGS | PhosphoSitePlus; HPRD; phosphoELM | |
S28 | SGPSGsLENGT | HPRD | |
S26 | SPSGPsGSLEN | HPRD | |
Y575 | HYRPFyVNKGN | PhosphoSitePlus | |
T476 | YSMYLtPKGGV | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
S58 | GKSLGsALKPG | HPRD | |
S538 | VQGSSsFSLKG | PhosphoSitePlus | |
S9 | ADASRsNGSSP | PhosphoSitePlus; HPRD | |
Y93 | DKNSNyFSMDS | PhosphoSitePlus; HPRD | |
Y474 | KRYSMyLTPKG | PhosphoSitePlus; HPRD | |
Y471 | DTMKRySMYLT | PhosphoSitePlus | |
Y544 | FSLKGyPSLMR | PhosphoSitePlus | |
S21 | ARDARsPSGPS | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
S13 | RSNGSsPEARD | PhosphoSitePlus; HPRD | |
S104 | MEGKRsPYAGL | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
Y485 | GVRTSyQPSSP | PhosphoSitePlus | |
T508 | NNLYGtKGNYT | PhosphoSitePlus | |
S540 | GSSSFsLKGYP | PhosphoSitePlus | |
S489 | SYQPSsPGRFT | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
T33 | SLENGtKADGK | PhosphoSitePlus; HPRD | |
Dephosphorylation site |
TRI29_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000343129 | P477S | COSMIC | Melanoma | 21499247 |
ENSP00000343129 | R434H | COSMIC | Renal Cancer | 20054297 |
ENSP00000343129 | S514F | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
ENSP00000343129 | S388T | COSMIC | Ovarian Cancer | 21720365 |
Differential expressed protein |
TRI29_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
TRI29_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
YES_HUMAN | TRI29_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
TRI29_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0005515 | protein binding | IPI | molecular_function |
GO:0006366 | transcription from RNA polymerase II promoter | TAS | biological_process |
GO:0005622 | intracellular | IEA | cellular_component |
GO:0002039 | p53 binding | IEA | molecular_function |
GO:0003700 | sequence-specific DNA binding transcription factor | TAS | molecular_function |
GO:0008270 | zinc ion binding | IEA | molecular_function |
GO:0005737 | cytoplasm | IEA | cellular_component |
GO:1900181 | negative regulation of protein localization to nuc | IEA | biological_process |
GO:0000122 | negative regulation of transcription from RNA poly | IEA | biological_process |